Malignant melanoma with liver and spleen metastases

case report

Authors

  • Laura Cotta Ornellas Universidade Federal de São Paulo
  • Valéria Pereira Lanzoni Universidade Federal de São Paulo
  • Carlos Fischer de Toledo Universidade Federal de São Paulo

Keywords:

Melanoma, Liver metastases, Spleen metastases

Abstract

CONTEXT: The diagnosis of primary melanoma is easily confirmed after histological analysis of the lesion, whereas it is rarely diagnosed when the patient even has distant metastases. DESIGN: Case report CASE REPORT: Malignant melanoma is responsible for about 1% of all deaths caused by cancer in the USA and only 3% of all malig-nant skin diseases. Malignant melanoma is a rare disease, although it corresponds to 65% of all deaths caused by skin cancer. The liver and spleen are rarely the first sites of melanoma metastases. This paper reports on the clinical picture of a patient with fatal malignant melanoma and hepatic and spleen metastases. As this was an un-usual presentation, the melanoma diagnosis could only be made after pathological analysis of the skin and hepatic lesions.

Downloads

Download data is not yet available.

Author Biographies

Laura Cotta Ornellas, Universidade Federal de São Paulo

MD. Clinical fellow, a fourth year medical graduate student of Gastroenterology Division, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Valéria Pereira Lanzoni, Universidade Federal de São Paulo

MD. Professor of Department of Pathology, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Carlos Fischer de Toledo, Universidade Federal de São Paulo

MD. Professor of Gastroenterology Division, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

References

Balch CM, Soong S, Murad TM, et al. A multifactorial analysis of melanoma IV. Prognostic factors in 200 melanoma patients with distant metastasis (Stage III). J Clin Oncol 1983;1(2):126-34.

Klaase JM, Kroon BBR. Surgery for melanoma metastatic to the gastrointestinal tract. Br J Surg 1990;77:60-1.

Mastrangelo MJ, Baker AR, Katz HR. Melanoma cutâneo. In: De Vita JRVT, Hellman S, Rosenberg SA, editors. Principios y práctica de oncologia, 2 a ed. Barcelona: Salvat Editores SA; 1988:1279-326.

Capizzi PJ, Donohue JH. Metastatic melanoma of the gastrointestinal tract: a review of the literature. Comprehensive Therapy 1994;20(1):20-3.

Das Gupta T, Brasfield R. Metastatic melanoma. Cancer 1964;17:1323-39.

Kew MC. Hepatic tumors and cysts. In: Feldman M, Fordtran JS, Scharschmidt BF, Sleisenger MH, editors. Gastrointestinal and liver disease, 6 th ed. Philadelphia: WB Saunders;1998:1364-87.

Foster JH, Ensminger WF. Tratamiento de las metástasis hepáticas. In: De Vita JRVT, Hellman S, Rosenberg SA, editors. Principios y práctica de oncologia, 2 a ed. Barcelona: Salvat Editores SA; 1988:1975-88.

Dahn MS, Lange MP, Kosir MA. Splanchnic metabolism associated with liver metastasis. Intensive Care Med 1995;21:352-5.

Brandberg Y, Bolunf C, Michelson H, et al. Perceived susceptibility to the knowledge of malignant melanoma: screening participants versus general population. Prev Med 1996;25:170-7.

Downloads

Published

2000-03-03

How to Cite

1.
Ornellas LC, Lanzoni VP, Toledo CF de. Malignant melanoma with liver and spleen metastases: case report. Sao Paulo Med J [Internet]. 2000 Mar. 3 [cited 2025 Mar. 15];118(2):53-6. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/2631

Issue

Section

Case Report